Treatment approaches and nursing applications for non-Hodgkin lymphoma.
Non-Hodgkin lymphoma (NHL), a malignancy that manifests in the lymphatic system, is one of the most commonly occurring hematologic disease types in the United States and other Westernized countries. NHL is divided into a range of subtypes with differing clinical features and outcomes. Depending on the type of NHL and the patient's overall clinical presentation, treatment varies from systemic combined chemotherapy regimens with or without immunotherapy, radioimmunotherapy, and transplants to investigational options. Oncology nurses play a vital role in implementing successful treatment and management of patients with NHL as oncology care moves into an era of novel targeted therapies.
Long
Jennifer M
JM
Whittingham Cancer Center, Norwalk Hospital, Connecticut, USA. jennifer.long@norwalkhealth.org
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D008228:Lymphoma, Non-Hodgkin / Q000145:classification / Q000451:nursing* / Q000473:pathology / Q000628:therapy*; D011480:Protease Inhibitors / Q000494:pharmacology; D061988:Proteasome Inhibitors; D016499:Radioimmunotherapy; D033581:Stem Cell Transplantation
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D011480:Protease Inhibitors; D061988:Proteasome Inhibitors